MX2013007371A - Peptidos de enlace her2 radiomarcados. - Google Patents

Peptidos de enlace her2 radiomarcados.

Info

Publication number
MX2013007371A
MX2013007371A MX2013007371A MX2013007371A MX2013007371A MX 2013007371 A MX2013007371 A MX 2013007371A MX 2013007371 A MX2013007371 A MX 2013007371A MX 2013007371 A MX2013007371 A MX 2013007371A MX 2013007371 A MX2013007371 A MX 2013007371A
Authority
MX
Mexico
Prior art keywords
radiolabled
binding peptides
her2 binding
her2
isolated polypeptide
Prior art date
Application number
MX2013007371A
Other languages
English (en)
Inventor
Rong Zhang
Brian Duh-Lan Lee
Paul Schaffer
Faisal Syud
Peter Iveson
Tove Eriksson
Elin Gunneriusson
Fredrik Frejd
Joachim Feldwisch
Lars Abrahmsen
Nina Herne
Christofer Lendel
Original Assignee
Affibody Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/975,425 external-priority patent/US20120165650A1/en
Application filed by Affibody Ab filed Critical Affibody Ab
Publication of MX2013007371A publication Critical patent/MX2013007371A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/008—Peptides; Proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nuclear Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se describen agentes formadores de imagen que comprenden un polipéptido aislado conjugado con un radionúclido y un quelatador; en donde el polipéptido aislado se une específicamente a HER2, o variante del mismo; y métodos para preparar y utilizar estos agentes formadores de imagen.
MX2013007371A 2010-12-22 2011-12-19 Peptidos de enlace her2 radiomarcados. MX2013007371A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12/975,425 US20120165650A1 (en) 2010-12-22 2010-12-22 Her2 binders
US201161438297P 2011-02-01 2011-02-01
US201161510520P 2011-07-22 2011-07-22
US201161541287P 2011-09-30 2011-09-30
PCT/US2011/065777 WO2012096760A1 (en) 2010-12-22 2011-12-19 Radiolabled her2 binding peptides

Publications (1)

Publication Number Publication Date
MX2013007371A true MX2013007371A (es) 2014-05-27

Family

ID=45444771

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2013007365A MX2013007365A (es) 2010-12-22 2011-12-19 Péptidos de enlace her2 etiquetados con fluoruro de aluminio- [18] combinados mediante nota.
MX2013007371A MX2013007371A (es) 2010-12-22 2011-12-19 Peptidos de enlace her2 radiomarcados.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2013007365A MX2013007365A (es) 2010-12-22 2011-12-19 Péptidos de enlace her2 etiquetados con fluoruro de aluminio- [18] combinados mediante nota.

Country Status (13)

Country Link
EP (4) EP3936155A1 (es)
JP (2) JP2014503546A (es)
KR (5) KR20180042442A (es)
CN (1) CN103533963B (es)
AU (2) AU2011349482A1 (es)
BR (2) BR112013015796A2 (es)
CA (3) CA2822815A1 (es)
IL (1) IL227003A (es)
MX (2) MX2013007365A (es)
NZ (2) NZ612312A (es)
RU (2) RU2592685C2 (es)
SG (2) SG191292A1 (es)
WO (2) WO2012096760A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120165650A1 (en) 2010-12-22 2012-06-28 General Electric Company Her2 binders
KR20180042442A (ko) * 2010-12-22 2018-04-25 제너럴 일렉트릭 캄파니 방사성표지 ｈｅｒ２ 결합 펩티드
WO2014076179A1 (en) * 2012-11-14 2014-05-22 Affibody Ab New polypeptide
WO2014124227A1 (en) * 2013-02-07 2014-08-14 Immunomedics, Inc. Pro-drug form (p2pdox) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer
CN103948947A (zh) * 2013-05-08 2014-07-30 南京市第一医院 以cd13为分子靶点、ngr为配体的放射性核素分子探针及其标记技术和应用
WO2014209205A1 (en) * 2013-06-27 2014-12-31 Ge Healthcare Limited Use of her2 binders
CN103833829A (zh) * 2014-01-07 2014-06-04 江苏省原子医学研究所 一种放射性18F标记的靶向肿瘤血管Anxa1显像药物18F-AL-NOTA-IF7及其制备方法
CN103951754B (zh) * 2014-03-26 2016-08-24 中国药科大学 一种靶向治疗和检测双功能的抗肿瘤双特异性小型化抗体
EP3015462A1 (en) * 2014-10-29 2016-05-04 OctreoPharm Schiences GmbH Enantiopure chelating agents for chelator coupled pharmaceuticals, corresponding preparation method thereof and chelator coupled pharmaceuticals
US10800797B2 (en) 2015-05-26 2020-10-13 California Institute Of Technology Heteroaromatic silicon-fluoride-acceptors useful for 18F labeling of molecules and biomolecules, and methods of preparing same
WO2017156034A1 (en) * 2016-03-10 2017-09-14 Becton, Dickinson And Company Methods of evaluating a cellular sample for her-2/neu expression and compositions for practicing the same
US10695450B2 (en) 2016-07-26 2020-06-30 Laboratoires Cyclopharma Synthesis of a radioactive agent composition
FR3054445B1 (fr) * 2016-07-26 2019-07-05 Laboratoires Cyclopharma Synthese d'une composition d'agent radioactif
WO2019055825A1 (en) 2017-09-15 2019-03-21 The Regents Of The University Of California INHIBITION OF AMINOACYLASE 3 (AA3) IN THE TREATMENT OF CANCER
CN110251695B (zh) * 2019-07-10 2021-12-21 莎穆(上海)生物科技有限公司 一种靶向her2的放射性配合物及其制备方法和应用
CN115244073A (zh) 2019-12-18 2022-10-25 伯拉考成像股份公司 抗her2多肽衍生物作为新的诊断分子探针
EP4077367A1 (en) 2019-12-18 2022-10-26 Bracco Imaging SPA Anti-her2 polypeptides derivatives as new diagnostic molecular probes
KR102502287B1 (ko) 2020-04-17 2023-02-22 앱클론(주) 항-her2 어피바디 및 이를 스위치 분자로 이용하는 스위처블 키메라 항원 수용체
CN116688165A (zh) * 2020-04-30 2023-09-05 霍伯生物技术公司 显像剂、其单位剂量和人类患者中her2表达的可视化方法
EP4446300A1 (en) 2023-04-14 2024-10-16 Trasis S.A. Preparation methods of aluminium fluoride complexes

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY133346A (en) * 1999-03-01 2007-11-30 Biogen Inc Kit for radiolabeling ligands with yttrium-90
US7563433B2 (en) * 2007-01-11 2009-07-21 Immunomedics, Inc. Methods and compositions for F-18 labeling of proteins, peptides and other molecules
US7993626B2 (en) * 2007-01-11 2011-08-09 Immunomedics, Inc. Methods and compositions for F-18 labeling of proteins, peptides and other molecules
US7772188B2 (en) * 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
GB0305704D0 (en) 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
ATE416190T1 (de) * 2003-07-04 2008-12-15 Affibody Ab Polypeptide mit bindungsaffinität für her2
GB0428012D0 (en) 2004-12-22 2005-01-26 Hammersmith Imanet Ltd Radiolabelling methods
WO2008049866A1 (en) * 2006-10-27 2008-05-02 Affibody Ab New chelating compound
US8303960B2 (en) * 2007-02-27 2012-11-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Radiolabeled affibody molecules
US8124725B2 (en) * 2007-12-19 2012-02-28 General Electric Company PDGF-Rβ binders
EP2072525A1 (en) * 2007-12-21 2009-06-24 Affibody AB New polypeptides having affinity for HER2
KR20180042442A (ko) * 2010-12-22 2018-04-25 제너럴 일렉트릭 캄파니 방사성표지 ｈｅｒ２ 결합 펩티드
KR20130132939A (ko) * 2010-12-22 2013-12-05 지이 헬쓰케어 리미티드 １８ｆ - 함유 유기실리콘 화합물로 표지된 ｈｅｒ２ 결합 펩티드

Also Published As

Publication number Publication date
KR102498607B1 (ko) 2023-02-13
KR20130132935A (ko) 2013-12-05
CN103491984A (zh) 2014-01-01
EP3957332A1 (en) 2022-02-23
SG191270A1 (en) 2013-07-31
EP3936155A1 (en) 2022-01-12
RU2013128361A (ru) 2015-01-27
CA3159948A1 (en) 2012-07-19
KR20180042442A (ko) 2018-04-25
NZ612312A (en) 2015-02-27
IL227003A (en) 2017-03-30
CA2822693A1 (en) 2012-07-19
KR20140045312A (ko) 2014-04-16
AU2011354599B2 (en) 2016-09-29
WO2012096760A1 (en) 2012-07-19
BR112013015796A2 (pt) 2017-03-21
RU2592685C2 (ru) 2016-07-27
BR112013015786A2 (pt) 2019-02-19
EP2654803A1 (en) 2013-10-30
RU2013128358A (ru) 2015-01-27
CN103533963B (zh) 2015-12-02
SG191292A1 (en) 2013-07-31
JP2014507400A (ja) 2014-03-27
NZ612161A (en) 2015-04-24
EP2654804A1 (en) 2013-10-30
CA2822693C (en) 2022-08-16
KR20230034403A (ko) 2023-03-09
WO2012087908A1 (en) 2012-06-28
KR20210059048A (ko) 2021-05-24
CA2822815A1 (en) 2012-06-28
AU2011354599A1 (en) 2013-07-25
EP2654803B1 (en) 2021-08-18
MX2013007365A (es) 2013-09-26
JP2014503546A (ja) 2014-02-13
CN103533963A (zh) 2014-01-22
AU2011349482A1 (en) 2013-07-25

Similar Documents

Publication Publication Date Title
MX2013007371A (es) Peptidos de enlace her2 radiomarcados.
SG191338A1 (en) Her2 binding peptides labelled with a 18f - containing organosilicon compound
PH12015501000A1 (en) Anti-notch3 antibodies and antibody-drug conjugates
IN2015DN02577A (es)
MX366813B (es) Polipeptidos de enlace cd3.
MX366303B (es) Pirrolobenzodiazepinas y conjugados de las mismas.
MX2019003214A (es) Formulaciones de proteina de inmunoglobulina del dominio variable dual estable.
HK1180601A1 (zh) 抗體製劑
EP2606061B8 (en) Binding proteins for hepcidin
TN2010000213A1 (en) Wise binding antibodies and epitopes
NZ703581A (en) Anti-cd70 antibody drug conjugates
EP3372617C0 (en) BINDING FUSION PROTEINS, BINDING FUSION PROTEIN-DRUG CONJUGATES, XTEN-DRUG CONJUGATES AND METHODS FOR PREPARING AND USING THEM
SG10201401681PA (en) Novel antigen binding proteins
MX338711B (es) Pirrolobenzodiazepinas y conjugados de las mismas.
EP2873678A4 (en) PEPTIDE PENETRATING IN A CELL, CONJUGATED COMPRISING SAME, AND COMPOSITION COMPRISING SAME
PL2625198T3 (pl) Przeciwciała rozpoznające fosfo-tau
IL222359A0 (en) Monoclonal antibodies against her2 antigens, and uses therefor
IL222270A (en) A monoclonal antibody or its segment, which is linked to a full-length human lif, a medical component that includes it and a process for preparing it
IL236236A (en) Antibodies to the fam26f polypeptide
MX2014001850A (es) Anticuerpos que enlazan alfa-v beta-8 integrina.
IN2012DN02073A (es)
IL226157A0 (en) Antigen binding proteins
MX2015004892A (es) Metodos y composiciones que se relacionan con anticuerpos de receptor anti-il-21.
HK1203150A1 (en) Improved processes for preparing peptide conjugates and linkers
AP4074A (en) Monoclonal antibody directed against the p17 protein of hiv, capable of neutralising the binding of p17 to the p17 receptor (p17r)